Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Fenofibrate119 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A46336 | 19463838 | Toxicol Appl Pharmacol | Gel entrapment culture of rat hepatocytes for investigation of tetracycline-induced toxicity. | 2009 | Details |
| A46919 | 34267188 | Cell Death Dis | Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. | 2021 | Details |
| A47770 | 32213649 | Endocrinol Diabetes Metab Case Rep | The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide. | 2020 | Details |
| A48214 | 19502591 | J Lipid Res | Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. | 2009 | Details |
| A49425 | 35754743 | PPAR Res | Liver Protective Effect of Fenofibrate in NASH/NAFLD Animal Models. | 2022 | Details |
| A49448 | 35746892 | Diabetes Metab J | Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice. | 2022 | Details |
| A49653 | 35678658 | Curr Issues Mol Biol | Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats. | 2022 | Details |
| A49992 | 35569762 | Drug Discov Today | Impact of fenofibrate on NAFLD/NASH: A genetic perspective. | 2022 | Details |
| A50017 | 35563117 | Int J Mol Sci | Functional and Structural Insights into Human PPARα/δ/γ Subtype Selectivity of Bezafibrate, Fenofibric Acid, and Pemafibrate. | 2022 | Details |
| A50192 | 35484544 | BMC Complement Med Ther | Lipotropic activities of aqueous extract of Vernonia guineensis Benth. in Wistar rats fed high fat diet. | 2022 | Details |
| A50532 | 35351574 | J Ethnopharmacol | Pretreatment of hydroethanolic extract of Dillenia indica L. attenuates oleic acid induced NAFLD in HepG2 cells via modulating SIRT-1/p-LKB-1/AMPK, HMGCR & PPAR-α signaling pathways. | 2022 | Details |
| A51306 | 35735253 | Hepatol Commun | Combinations of an acetyl CoA carboxylase inhibitor with hepatic lipid modulating agents do not augment antifibrotic efficacy in preclinical models of NASH and fibrosis. | 2022 | Details |
| A51630 | 35483558 | Biochim Biophys Acta Mol Cell Biol Lipids | The effect of black seed (Nigella sativa) extract on lipid metabolism in HepG2 cells. | 2022 | Details |
| A51914 | 33273564 | Sci Rep | Short-term Cudrania tricuspidata fruit vinegar administration attenuates obesity in high-fat diet-fed mice by improving fat accumulation and metabolic parameters. | 2020 | Details |
| A52172 | 30429322 | Proc Natl Acad Sci U S A | Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice. | 2018 | Details |
| A52533 | 25906681 | Biochim Biophys Acta | Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice. | 2015 | Details |
| A52999 | 17935055 | Diab Vasc Dis Res | Preventing type 2 diabetes and cardiovascular disease in metabolic syndrome: the role of PPARalpha. | 2007 | Details |
| A53050 | 16477380 | Mol Cell Biochem | Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice. | 2006 | Details |
| A53099 | 14728015 | Am J Cardiovasc Drugs | Drug treatment of combined hyperlipidemia. | 2001 | Details |